Oncodesign Services, a Leading European CRO In Preclinical Drug Discovery Acquires ZoBio, A CRO Specialized in Small Molecule Drug Discovery
Acquiring Company
Oncodesign Services
Acquired Company
ZoBio
Dijon
LeidenBiotechnologyBiotechnologyDescription
Oncodesign Services (ODS), a leading Contract Research Organization specialized in drug discovery and preclinical services, has announced its acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery. This acquisition allows ODS to strengthen and extend its expertise and capabilities in the field of small molecule discovery, offering a fully integrated offering to support its customers' innovative programs from target validation to candidate selection.
Quick answer
Oncodesign Services is acquiring ZoBio, announced January 23, 2024. Oncodesign Services is based in Dijon, Bourgogne – Franche-Comté, France.
- How much did Oncodesign Services pay for ZoBio?
- The deal value was not disclosed.
- What does Oncodesign Services do?
- Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services.
- Where are Oncodesign Services and ZoBio based?
- Oncodesign Services is based in Dijon, Bourgogne – Franche-Comté, France. ZoBio is based in Leiden, South Holland, Netherlands.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Bruker Corporation completes acquisition of Chemspeed Technologies AG to expand vendor-agnostic scientific software and laboratory automation (March 7, 2024)
- Telix Pharmaceuticals Limited to acquire ARTMS Inc. and its Advanced Isotope Production Platform (March 4, 2024)
- Branded Legacy, Inc. signs letter of intent to purchase Sycamore BioPharma, LLC, to strengthen its position in the BioTech industry (March 1, 2024)
- STEMCELL Technologies completes acquisition of substantially all assets of SQZ Biotechnologies (February 29, 2024)
- Ginkgo Bioworks Acquires Proof Diagnostics, Growing Gene Editing Service Offerings for its Customers (February 28, 2024)
- Bristol Myers Squibb Completes Acquisition of RayzeBio, Adding Differentiated Actinium-Based Radiopharmaceutical Platform (February 26, 2024)
Who to call at Oncodesign Services, and when
When Oncodesign Services changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Oncodesign Services raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oncodesign Services, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oncodesign Services. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oncodesign Services makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired ZoBio?
ZoBio was acquired by Oncodesign Services, based in Dijon. The deal was reported on January 23, 2024. Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Oncodesign Services is privately held and operates in Biotechnology.
When did Oncodesign Services acquire ZoBio?
Oncodesign Services's acquisition of ZoBio was reported on January 23, 2024. Oncodesign Services (ODS), a leading Contract Research Organization specialized in drug discovery and preclinical services, has announced its acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ZoBio do?
ZoBio has built a class-leading platform that provides a complete solution for Fragment Based Drug Discovery to our clients. It is privately held, operating in Biotechnology, and is based in Leiden.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.